L ncRNA‐XIST/microRNA‐126 sponge mediates cell proliferation and glucose metabolism through the IRS1/PI3K/Akt pathway in glioma

Long Noncoding RNA-ATB Impairs the Function of Tumor Suppressor miR-126-Mediated Signals in Endometrial Cancer for Tumor Growth and Metastasis

(2019) Xia Zheng et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

The Ambivalent Role of lncRNA Xist in Carcinogenesis

(2019) Yung-Kang Chen et al.   Stem Cell Reviews and Reports

LncRNA XIST accelerates cervical cancer progression via upregulating Fus through competitively binding with miR-200a

(2018) Hong Zhu et al.   BIOMEDICINE & PHARMACOTHERAPY

LncRNA XIST/miR-200c regulates the stemness properties and tumourigenicity of human bladder cancer stem cell-like cells

(2018) Ran Xu et al.   Cancer Cell International

Glucose homeostasis, nutrition and infections during critical illness

(2018) C. Ingels et al.   CLINICAL MICROBIOLOGY AND INFECTION

Glucose transporters in cancer - from tumor cells to the tumor microenvironment

(2018) Pierre-Benoit Ancey et al.   FEBS Journal

Long non-coding RNA HOTAIR acts as a competing endogenous RNA to promote glioma progression by sponging miR-126-5p

(2018) Liang Liu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma

(2018) Yang Yuan et al.   JOURNAL OF NEURO-ONCOLOGY

LncRNA XIST Promotes Pancreatic Cancer Proliferation Through miR-133a/EGFR

(2017) Wei Wei et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Multidrug resistance in glioblastoma stem-like cells: Role of the hypoxic microenvironment and adenosine signaling

(2017) Daniel Uribe et al.   MOLECULAR ASPECTS OF MEDICINE

Role of long non-coding RNAs in glucose metabolism in cancer

(2017) Chunmei Fan et al.   Molecular Cancer

Down-regulation of MicroRNA-126 in Glioblastoma and its Correlation with Patient Prognosis: A Pilot Study

(2016) IN BO HAN et al.   ANTICANCER RESEARCH

lncRNANBR2modulates cancer cell sensitivity to phenformin through GLUT1

(2016) Xiaowen Liu et al.   CELL CYCLE

Suppressing H19 Modulates Tumorigenicity and Stemness in U251 and U87MG Glioma Cells

(2016) Weiguo Li et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor

(2016) Takuya Toyonaga et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapy

(2016) Christos E. Zois et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

MiR-126 Regulates the ERK Pathway via Targeting KRAS to Inhibit the Glioma Cell Proliferation and Invasion

(2016) Yang Li et al.   MOLECULAR NEUROBIOLOGY

Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme

(2016) Kun Zhang et al.   ONCOLOGY REPORTS

Regulation of Glucose Metabolism – A Perspective From Cell Bioprocessing

(2016) Bhanu Chandra Mulukutla et al.   TRENDS IN BIOTECHNOLOGY

Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α–ZEB1 axis

(2015) Justin V. Joseph et al.   CANCER LETTERS

Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152

(2015) Yilong Yao et al.   CANCER LETTERS

Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression

(2015) Zhaoyong Li et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Dual-targeting of aberrant glucose metabolism in glioblastoma

(2015) Han Shen et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Stem cell signature in glioblastoma: therapeutic development for a moving target

(2015) Ichiro Nakano   JOURNAL OF NEUROSURGERY

The emerging role of lncRNAs in cancer

(2015) Maite Huarte   NATURE MEDICINE

Glycogen metabolism in cancer

(2014) Christos E. Zois et al.   BIOCHEMICAL PHARMACOLOGY

Proneural–mesenchymal transformation of glioma stem cells: do therapies cause evolution of target in glioblastoma?

(2014) Ichiro Nakano   Future Oncology

Using the molecular classification of glioblastoma to inform personalized treatment

(2013) Adriana Olar et al.   JOURNAL OF PATHOLOGY

Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway

(2013) Jiri Polivka et al.   PHARMACOLOGY & THERAPEUTICS

Down-Regulation of miR-126 Is Associated with Colorectal Cancer Cells Proliferation, Migration and Invasion by Targeting IRS-1 via the AKT and ERK1/2 Signaling Pathways

(2013) Yu Zhou et al.   PLoS One

Knockdown of NYGGF4 increases glucose transport in C2C12 mice skeletal myocytes by activation IRS-1/PI3K/AKT insulin pathway

(2012) Xue-Qi Zeng et al.   JOURNAL OF BIOENERGETICS AND BIOMEMBRANES

Targeting glucose metabolism for cancer therapy: Figure 1.

(2012) Robert B. Hamanaka et al.   JOURNAL OF EXPERIMENTAL MEDICINE

How cancer metabolism is tuned for proliferation and vulnerable to disruption

(2012) Almut Schulze et al.   NATURE

IGF-1 induces hypoxia-inducible factor 1α-mediated GLUT3 expression through PI3K/Akt/mTOR dependent pathways in PC12 cells

(2011) Jian Yu et al.   BRAIN RESEARCH

The Emergence of lncRNAs in Cancer Biology

(2011) J. R. Prensner et al.   Cancer Discovery

Over-expression of NYGGF4 (PID1) inhibits glucose transport in skeletal myotubes by blocking the IRS1/PI3K/AKT insulin pathway

(2010) W.L. Wu et al.   MOLECULAR GENETICS AND METABOLISM

Glut1 and Glut3 as Potential Prognostic Markers for Oral Squamous Cell Carcinoma

(2010) Fernanda Rocha Rojas Ayala et al.   MOLECULES

Glioblastoma Cells Require Glutamate Dehydrogenase to Survive Impairments of Glucose Metabolism or Akt Signaling

(2009) C. Yang et al.   CANCER RESEARCH

Metabolic Enzymes as Oncogenes or Tumor Suppressors

(2009) Craig B. Thompson   NEW ENGLAND JOURNAL OF MEDICINE

The cell growth suppressor, mir-126, targets IRS-1

(2008) Jin Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS